Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes.
Evan D BanderMelissa YuanAnne S ReinerAndrew L A GartonKatherine S PanageasCameron W BrennanViviane TabarNelson S MossPublished in: Journal of neuro-oncology (2021)
CSF diversion for LM with hydrocephalus and intracranial hypertension secondary to metastasis can achieve symptomatic relief, hospital discharge, and return to further oncologic therapy, with a complication profile unique to this pathophysiology. However, decision-making in this population must incorporate end-of-life goals of care given limited prognosis.
Keyphrases
- cerebrospinal fluid
- robot assisted
- palliative care
- blood pressure
- rectal cancer
- radical prostatectomy
- healthcare
- minimally invasive
- quality improvement
- prostate cancer
- advanced cancer
- pain management
- type diabetes
- bone marrow
- metabolic syndrome
- public health
- mesenchymal stem cells
- affordable care act
- insulin resistance
- skeletal muscle
- smoking cessation